Kalexate

Active Ingredient(s): Sodium Polystyrene Sulfonate
FDA Approved: * March 30, 2009
Pharm Company: * KVK TECH
Category: Potassium Levels

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Kalexate Overview

Polystyrene sulfonates are polymers derived from polystyrene by the addition of sulfonate functional groups. They are widely used as ion-exchange resins to remove ions such as potassium, calcium, and sodium from solutions in technical or medical applications. Linear ionic polymers are generally water-soluble, whereas cross-linked materials (called resins) do not dissolve in water. These polymers are classified as polysalts and ionomers.[1] Contents 1 Medical uses 2 Contrai...

Read more Kalexate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Kionex

Recent Kalexate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Polystyrene Sulfonate
  • Powder: 15gm/bot, 453.6gm/bot, 454g, 454gm/bot
  • Powder for Reconstitution: 100%, 15g/60ml, 4.1meq/g
  • Suspension: 15g/60ml, 15gm/60ml, 30g/120ml, 50g/200ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Sodium Polystyrene Sulfonate or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 September 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA